Companies

Surgical Innovations

Overview

Surgical Innovations' core business is developing instruments for keyhole or minimally invasive surgery. It has been involved in the sector since 1992 and it reversed into Aim-quoted Haemocell in 1998. The Haemocell part of the group is involved in autologous blood transfusion, which is the practice of collecting a patient's blood and re-infusing it into the body. This cuts out the risk of infection from donated blood.

Sector: Health

• Surgical Innovation Posted: 02/08/2007

News blog

• Surgical Innovations Posted: 09/01/2017
• Surgical Innovations Posted: 12/05/2015
• Surgical Innovations Posted: 11/03/2015
• Surgical Innovations Posted: 06/11/2014
• Surgical Innovations Posted: 19/09/2014
• Surgical Innovations Posted: 21/04/2014
• Surgical Innovations Posted: 19/04/2013
• Surgical Innovations Posted: 25/05/2010
• Surgical Innovations Posted: 05/04/2010
• Surgical Innovations Posted: 29/09/2008
• Surgical Innovations Posted: 29/04/2008

Browse by sector

All companies

• Aim advisers
• Aim Awards
• Aim investor relations
• Cleantech
• Construction
• Consumer
• Electricals
• Financial
• Food
• Health
• Industrial
• Leisure
• Media
• Mobile
• Property
• QUOTED MICRO
• Resources
• Retail
• Security
• Services
• Technology
• Telecoms
• Training
• Transport

• 2.4mNumber of messages posted on SocialGo networks
  
• $38mCost savings generated by ideas from WalMart staff over a two month period